 |
Kzhq Record 6.6 Million In Correctional System
Thomas McGowan s journey from prison to prosperity is about to culminate in $1.8 million, and he knows just how to spend it: on a house with three bedrooms, stainless steel kitchen appliances and a washer and dryer. I ll let my girlfriend pick out the rest, said McGowan, who was exonerated l <a href=https://www.stanley-cups.ca>stanley cup</a> ast year based on DNA evidence after spending nearly 23 years in prison for rape and robbery.He and other exonerees in Texas, which leads the nation in freeing the wrongly convicted, soon <a href=https://www.stanley-cups.us>stanley website</a> will become instant millionaires under a new state law that took effect this week. Exonerees will get $80,000 for each year they spent behind bars. The compensation also includes lifetime annuity payments that for most of the wrongly convicted are worth between $40,000 and $50,000 a year - making it by far the nation s most generous package. I m nervous and excited, said McGowan, 50. It s something I never had, this amount of money. I didn t have any money - period. His payday for his imprisonment - a time he described as a nightmare, hell and slavery - should come by mid-November after the state s 45-day processing period.Exonerees also receive an array of social services, including job training, tuition credits and access to medical and dental treatment. Though 27 other states have some form of compensation law for the wrongly convicted, none comes close to <a href=https://www.stanley-cups.us>stanley us</a> offering the social services and money Texas provides.The annuity payments are especially po Omdu Al Doury s Group Release First Compilation Video
For adults with <a href=https://www.salomonschuhe.com.de>salomon sommerschuhe</a> complicated urinary tract infections, a new drug has been approved by the U.S. Food and Drug Administration.Vabomere is an antibacterial drug that inhibits certain types of resistance mechanisms used by bacteria, the FDA said in a news release today. The FDA is committed to making new safe and effective antibacterial drugs available, said Edward Cox, M.D., director of the Office of Antimicrobial Products in the FDAs Center for Drug Evaluation and Research. This approval provides an additional treatment option for patients with cUTI, a type of serious bacterial infection. In a clinical trial with 545 adultswith complicated UTIs, 98 percent given the intravenous treatment improved. Seven days following treatment, 77 percent had resolved symptoms, the FDA said. The FDA granted approval of Vabomere to Rempex Pharmaceutical <a href=https://www.crocss.com.de>crocs schuhe</a> s, the release said.A cUTI is different from a UTI in that the person who has one typically has another abnormality that leads to the complication, acc <a href=https://www.yeezy.com.mx>yeezy</a> ording to the National Institutes of Health. |